News

August 12, 2020August 12, 2020

Liquida’s LIQ861 Found to Improve Exercise Capacity, Quality of Life in PAH

News, PAH News

LIQ861, Liquidia Technologies’ proprietary inhaled dry powder formulation of the vasodilator treprostinil, improves exercise capacity and quality of life for people with pulmonary arterial hypertension (PAH), according to data ... Read more

August 11, 2020August 11, 2020

New Streaming Channel Showcases Rare Disease Films

News, syndicated

When the COVID-19 pandemic forced the postponement of a rare disease film festival originally slated for May, its organizers set out to find a new way to bring the ... Read more

August 10, 2020August 10, 2020

5-year Survival Rate Lower in Congenital Heart Disease Patients With PAH

News, PAH News

The five-year survival rate is markedly reduced among adults with pulmonary arterial hypertension (PAH) due to congenital heart disease (CHD), compared with other types of CHD, real-world data from ... Read more

August 7, 2020August 7, 2020

Aerovate Raises $72.6M to Develop Potential PAH Inhaled Therapy AV-101

News, PAH News

Aerovate Therapeutics received $72.6 million in Series A funding to advance trials testing AV-101, an experimental inhaled version of imatinib for the treatment of pulmonary arterial hypertension (PAH). AV-101 is ... Read more

August 5, 2020August 5, 2020

Free Online ‘Bootcamp’ Aims to Help Those With Lingering COVID-19 Effects

News

To help people experiencing the lingering effects of coronavirus infection, the Pulmonary Wellness Foundation (PWF) has launched a free online rehabilitation and recovery program called COVID Bootcamp 101. In ... Read more

August 3, 2020August 3, 2020

PVR Threshold for Mortality Risk Lower Than Previously Thought, Study Suggests

News

High pulmonary vascular resistance (PVR) is associated with worse mortality rates among people with pulmonary hypertension (PH), and the bottom threshold for what constitutes “elevated” PVR is lower than previously thought, ... Read more

July 31, 2020July 31, 2020

Klotho Protein Supplements Improve Pulmonary, Cardiac Function in BPD Rat Model

News, PH News

Preterm babies with the lung condition bronchopulmonary dysplasia (BPD) — a risk factor for the development of pulmonary hypertension (PH) — have lower levels of the anti-aging-associated protein Klotho, ... Read more

July 29, 2020July 29, 2020

PAH Caused by Undiagnosed Systemic Sclerosis in Case Study

News, PAH News

A case report found a patient’s pulmonary arterial hypertension (PAH) was caused by an undiagnosed case of the autoimmune disorder systemic sclerosis (SSc), highlighting the need for early and thorough ... Read more

July 27, 2020July 27, 2020

Outcomes Better for PAH Patients Treated at Specialty Centers, Study Finds

News, PAH News

People with pulmonary arterial hypertension (PAH) who are treated at specialty care centers have better survival chances and a lower likelihood of hospitalization, a study reports. These findings support ... Read more

July 24, 2020July 24, 2020

Patient Advocate in Latin America Wins Team PHenomenal Hope Research Grant

News, PH News

Paula Menezes has been awarded a $50,000 PHenomenal Impact Fund for Global PH Research grant to identify challenges faced by pulmonary hypertension (PH) patients and caregivers in parts of ... Read more

Pin It on Pinterest